Latest Insider Transactions at Healthcare Services Group Inc (HCSG)
This section provides a real-time view of insider transactions for Healthcare Services Group Inc (HCSG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HEALTHCARE SERVICES GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HEALTHCARE SERVICES GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2024
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,816
+8.97%
|
-
|
|
Dec 31
2023
|
Theodore Wahl President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+0.65%
|
$16,664
$8.81 P/Share
|
|
Dec 31
2023
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,083
+11.25%
|
$16,664
$8.81 P/Share
|
|
Dec 31
2023
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
242
+1.08%
|
$2,420
$10.37 P/Share
|
|
Dec 31
2023
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,447
+11.24%
|
$14,470
$10.37 P/Share
|
|
Sep 30
2023
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,439
+12.6%
|
$14,390
$10.43 P/Share
|
|
Sep 30
2023
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+1.08%
|
$2,400
$10.43 P/Share
|
|
Jun 30
2023
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+0.77%
|
$2,352
$14.93 P/Share
|
|
Jun 30
2023
|
Kurt Simmons Jr Director |
BUY
Open market or private purchase
|
Direct |
1,005
+10.53%
|
$14,070
$14.93 P/Share
|
|
May 30
2023
|
Daniela Castagnino Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+30.46%
|
$39,690
$14.11 P/Share
|
|
May 30
2023
|
Diane S Casey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+30.46%
|
$39,690
$14.11 P/Share
|
|
May 30
2023
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+30.46%
|
$39,690
$14.11 P/Share
|
|
May 30
2023
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+11.62%
|
$39,690
$14.11 P/Share
|
|
May 30
2023
|
Dino D Ottaviano Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+29.1%
|
$39,690
$14.11 P/Share
|
|
May 30
2023
|
John J Mc Fadden Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+30.46%
|
$39,690
$14.11 P/Share
|
|
May 30
2023
|
Jude Visconto Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+30.46%
|
$39,690
$14.11 P/Share
|
|
May 30
2023
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,835
+27.33%
|
$39,690
$14.11 P/Share
|
|
Mar 31
2023
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
181
+0.96%
|
$2,353
$13.87 P/Share
|
|
Mar 31
2023
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,082
+18.71%
|
$14,066
$13.87 P/Share
|
|
Feb 24
2023
|
Andrew M Brophy Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
951
-20.7%
|
$12,363
$13.41 P/Share
|
|
Feb 24
2023
|
Andrew M Brophy Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,644
+44.23%
|
-
|
|
Feb 21
2023
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,722
-2.69%
|
$122,108
$14.47 P/Share
|
|
Feb 21
2023
|
Theodore Wahl President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,346
+2.8%
|
$130,844
$14.47 P/Share
|
|
Jan 04
2023
|
Theodore Wahl President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,919
-5.66%
|
-
|
|
Jan 04
2023
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,818
+3.15%
|
-
|
|
Jan 04
2023
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,661
-13.16%
|
-
|
|
Jan 04
2023
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,762
+6.66%
|
-
|
|
Jan 04
2023
|
Patrick J Orr EVP & Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,463
-14.65%
|
-
|
|
Jan 04
2023
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,831
+7.43%
|
-
|
|
Jan 04
2023
|
Andrew Kush EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,215
-14.06%
|
-
|
|
Jan 04
2023
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,218
+7.45%
|
-
|
|
Jan 04
2023
|
John Christopher Shea EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,218
-11.46%
|
-
|
|
Jan 04
2023
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,219
+5.94%
|
-
|
|
Jan 04
2023
|
Andrew M Brophy Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-18.65%
|
-
|
|
Jan 04
2023
|
Andrew M Brophy Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
718
+19.1%
|
-
|
|
Jan 03
2023
|
Theodore Wahl President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,547
+4.81%
|
-
|
|
Jan 03
2023
|
Theodore Wahl President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,405
+0.5%
|
$14,050
$10.2 P/Share
|
|
Jan 03
2023
|
Jason J Bundick EVP/Gen. Counsel/Corp. Secty. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,817
+10.52%
|
-
|
|
Jan 03
2023
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,289
+9.05%
|
-
|
|
Jan 03
2023
|
Patrick J Orr EVP & Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,405
+11.61%
|
$14,050
$10.2 P/Share
|
|
Jan 03
2023
|
Andrew Kush EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,818
+10.26%
|
-
|
|
Jan 03
2023
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,818
+8.22%
|
-
|
|
Jan 03
2023
|
John Christopher Shea EVP & Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,405
+5.17%
|
$14,050
$10.2 P/Share
|
|
Jan 03
2023
|
Andrew M Brophy Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
123
+20.53%
|
-
|
|
Dec 08
2022
|
Theodore Wahl President & CEO |
SELL
Bona fide gift
|
Indirect |
5,140
-6.19%
|
$66,820
$13.07 P/Share
|
|
May 31
2022
|
Daniela Castagnino Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+39.05%
|
$39,610
$17.17 P/Share
|
|
May 31
2022
|
Diane S Casey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+39.05%
|
$39,610
$17.17 P/Share
|
|
May 31
2022
|
Kurt Simmons Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+39.16%
|
$39,610
$17.17 P/Share
|
|
May 31
2022
|
Laura K Grant Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+39.05%
|
$39,610
$17.17 P/Share
|
|
May 31
2022
|
Robert L Frome Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+11.16%
|
$39,610
$17.17 P/Share
|